Why the MyFiziq (ASX:MYQ) share price is falling today

The MyFiziq Ltd (ASX: MYQ) share price has dropped 2.22% today following the release of an update for its cash inflows.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The MyFiziq Ltd (ASX: MYQ) share price has fallen lower today following the release of an update for its cash inflows.

At the time of writing, the software company's shares are down 2.22% to $1.32. In comparison, the All Ordinaries Index (ASX: XAO) is flat at 6,413 points.

Young investor watching share chart in anticipation

Image source: Getty Images

Strong inflow of funding and payments

MyFiziq updated the market with an overview of its funding and payments for the past few months. Here is a breakdown of its latest developments.

As announced earlier this week, MyFiziq has received firm commitments to raise $5 million from an oversubscribed capital raising.

On June 1, MyFiziq entered a convertible note funding agreement with Asia Cornerstone Asset Management (ACAM). Under the agreement, MyFiziq was due to receive US$1.5 million in four tranches. So far, three of these tranches have been received with a value of US$1.125 million.

Within the agreement, ACAM advised it won't be taking up the final tranche of convertible notes. However, to satisfy the deed, ACAM will subscribe iConcept Global Growth Fund (IGGF) to the notes. IGGF paid the remaining balance of US$375,000.

In addition, IGGF subscribed for $332,500 worth of shares in Body Composition Technologies (BCT) as part of a second tranche of financing. MyFiziq said it received funds this week with a licence payment from BCT of $121,794 and development revenues of $70,706.

On a closing note, MyFiziq stated the Australian Taxation Office reimbursed $784,412 from its R&D projects. The company said this was the largest refund to date and will seek to focus on its strategic developments.

What did the CEO say?

MyFiziq CEO, Vlado Bosanac said:

The week has closed out on a very positive note, with a $5,000,000 oversubscribed capital raising, which was enhanced with additional inflows from our US NASDAQ funding initiative, A TO R&D reimbursements, a license payment from BCT and other partner revenues.

These additional inflows resulted in a further $1,504,977 in funding to the company. I am pleased to say the company is in the best financial position it has been in for the past few years, with ample capital to accelerate growth and execute on our NASDAQ initiatives.

MyFiziq share price summary

The MyFiziq share price has been on tear since August, after announcing a raft of positive agreements and term sheets. This propelled its shares from 28 cents to now $1.34, representing a gain of 380% for shareholders. At a market capitalisation of $154 million, MyFiziq has been accelerating its growth strategy to become a market leader in its field.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Two happy and excited friends in euphoria holding a smartphone, after winning in a bet.
Broker Notes

3 ASX shares upgraded by Morgans to buy ratings

Let's see why the broker has turned positive on these shares.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing start to the trading week.

Read more »

Successful group of people applauding in a business meeting and looking very happy.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Wooden blocks spelling rebound with coins on top.
Broker Notes

Can Life360 shares recover from the AI fuelled sell-off?

A leading expert looks into the AI-driven pressure hitting Life360 shares.

Read more »

An engineer takes a break on a staircase and looks out over a huge open pit coal mine as the sun rises in the background.
Broker Notes

Up 49% in a year, should you buy BHP shares for their 'stability and income'?

A leading expert delivers his forecast for BHP’s fast-rising shares.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: Pro Medicus, Life360, A2 Milk shares

Expert analysts reveal their latest recommendations on 3 ASX 200 stocks.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Atlas Arteria, Forrestania, Megaport, and WA1 shares are charging higher today

These shares are starting the week positively. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Cochlear, Karoon Energy, Origin Energy, and WiseTech shares are falling today

These shares are starting the week in the red. Let's find out why.

Read more »